Position in LFCR
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$10,687
New position
Shares Held
2,873
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MEEDER ASSET MANAGEMENT INC holds $6,515,197 across 13 Drug Manufacturers - Specialty & Generic names. LFCR ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
45,286 | $5,353,254 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,503 | $891,246 | |
| 3 | PAHC |
Phibro Animal Health Corp
|
1,969 | $108,905 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
2,036 | $46,013 | |
| 5 | VTRS |
Viatris Inc
|
1,643 | $22,196 | |
| 6 | PRGO |
PERRIGO Co plc
|
1,976 | $21,222 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
2,057 | $17,073 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
474 | $11,342 |
All Filings in LFCR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,687 | 2,873 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||